222 related articles for article (PubMed ID: 22262811)
1. Metformin reduces endogenous reactive oxygen species and associated DNA damage.
Algire C; Moiseeva O; Deschênes-Simard X; Amrein L; Petruccelli L; Birman E; Viollet B; Ferbeyre G; Pollak MN
Cancer Prev Res (Phila); 2012 Apr; 5(4):536-43. PubMed ID: 22262811
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone and metformin have opposite effects on intestinal absorption of oligopeptides via the proton-dependent PepT1 transporter.
Hindlet P; Barraud C; Boschat L; Farinotti R; Bado A; Buyse M
Mol Pharmacol; 2012 Mar; 81(3):319-27. PubMed ID: 22108913
[TBL] [Abstract][Full Text] [Related]
3. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling.
Calvert JW; Gundewar S; Jha S; Greer JJ; Bestermann WH; Tian R; Lefer DJ
Diabetes; 2008 Mar; 57(3):696-705. PubMed ID: 18083782
[TBL] [Abstract][Full Text] [Related]
4. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.
Zakikhani M; Dowling R; Fantus IG; Sonenberg N; Pollak M
Cancer Res; 2006 Nov; 66(21):10269-73. PubMed ID: 17062558
[TBL] [Abstract][Full Text] [Related]
5. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
[TBL] [Abstract][Full Text] [Related]
6. Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt.
Janjetovic K; Vucicevic L; Misirkic M; Vilimanovich U; Tovilovic G; Zogovic N; Nikolic Z; Jovanovic S; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
Eur J Pharmacol; 2011 Jan; 651(1-3):41-50. PubMed ID: 21114978
[TBL] [Abstract][Full Text] [Related]
7. Metformin induces suppression of NAD(P)H oxidase activity in podocytes.
Piwkowska A; Rogacka D; Jankowski M; Dominiczak MH; Stepiński JK; Angielski S
Biochem Biophys Res Commun; 2010 Mar; 393(2):268-73. PubMed ID: 20123087
[TBL] [Abstract][Full Text] [Related]
8. Metformin Protects Kidney Cells From Insulin-Mediated Genotoxicity In Vitro and in Male Zucker Diabetic Fatty Rats.
Othman EM; Oli RG; Arias-Loza PA; Kreissl MC; Stopper H
Endocrinology; 2016 Feb; 157(2):548-59. PubMed ID: 26636185
[TBL] [Abstract][Full Text] [Related]
9. Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C.
Mahrouf M; Ouslimani N; Peynet J; Djelidi R; Couturier M; Therond P; Legrand A; Beaudeux JL
Biochem Pharmacol; 2006 Jul; 72(2):176-83. PubMed ID: 16730666
[TBL] [Abstract][Full Text] [Related]
10. Metformin and insulin meet in a most atypical way.
White MF
Cell Metab; 2009 Jun; 9(6):485-7. PubMed ID: 19490902
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
12. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells.
Zhou Q; Liu LZ; Fu B; Hu X; Shi X; Fang J; Jiang BH
Carcinogenesis; 2007 Jan; 28(1):28-37. PubMed ID: 16774940
[TBL] [Abstract][Full Text] [Related]
14. Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth.
Algire C; Zakikhani M; Blouin MJ; Shuai JH; Pollak M
Endocr Relat Cancer; 2008 Sep; 15(3):833-9. PubMed ID: 18469156
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of inhibition of hepatic glucose production by metformin: a new concept for an old remedy].
Foretz M; Viollet B
Med Sci (Paris); 2010; 26(6-7):663-6. PubMed ID: 20619173
[No Abstract] [Full Text] [Related]
16. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
Gallagher EJ; LeRoith D
Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
[TBL] [Abstract][Full Text] [Related]
17. Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin.
Bellin C; de Wiza DH; Wiernsperger NF; Rösen P
Horm Metab Res; 2006 Nov; 38(11):732-9. PubMed ID: 17111300
[TBL] [Abstract][Full Text] [Related]
18. Controlling tumor growth by modulating endogenous production of reactive oxygen species.
Laurent A; Nicco C; Chéreau C; Goulvestre C; Alexandre J; Alves A; Lévy E; Goldwasser F; Panis Y; Soubrane O; Weill B; Batteux F
Cancer Res; 2005 Feb; 65(3):948-56. PubMed ID: 15705895
[TBL] [Abstract][Full Text] [Related]
19. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits macrophage cholesterol biosynthesis rate: possible role for metformin-induced oxidative stress.
Koren-Gluzer M; Aviram M; Hayek T
Biochem Biophys Res Commun; 2013 Sep; 439(3):396-400. PubMed ID: 23994636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
